Feature

Will coronavirus restrictions lead to more advanced cancers?


 

Metaphors of war

These assumptions fall apart now that we are facing a real societal disease, an infectious disease outbreak. Coronavirus has made us reflect on what actions individuals should take in order to protect others. But cancer is not a contagion. When we decide whether and how to screen, we make intimate decisions affecting primarily ourselves and our family – not society at large.

Countless articles have been written about the use of metaphor in cancer, perhaps most famously by essayist and breast cancer patient Susan Sontag. Sontag and others have been critical of the rampant use of war metaphors in the cancer community. Wars invoke sacrifice, duty, and suffering. The “battle” against coronavirus really puts the “war on cancer” in perspective. These pandemic weeks have terrified me. I have been willing to do anything to protect myself and others. They’ve also exhausted me. We can’t be at war forever.

When this current war ends, will the “war on cancer” resume unchanged? Screening will no doubt begin again, hopefully improved by data from the coronavirus natural experiment. But I wonder whether we will tolerate the same kinds of public health messages – and whether we should – having now experienced an infectious disease outbreak where our actions as individuals really do have an impact on the health of others.

After feeling helpless, besieged, and even guilt-ridden during the pandemic, I think many people would appreciate regaining a sense of control over other aspects of their health. Cancer screening can save lives, but it’s a choice we should make for ourselves based on an understanding of the trade-offs and our own preferences. When screening restarts, I hope its paternalistic dogma can be replaced by nuanced, empowering tactics more appropriate for peacetime.

Benjamin Mazer, MD, MBA, is an anatomic and clinical pathology resident at Yale with interests in diagnostic surgical pathology, laboratory management, and evidence-based medicine.

This article first appeared on Medscape.com.

Pages

Recommended Reading

‘Brutal’ plan to restrict palliative radiation during pandemic
Federal Practitioner
Conducting cancer trials amid the COVID-19 pandemic
Federal Practitioner
Managing pediatric heme/onc departments during the pandemic
Federal Practitioner
Home-based chemo skyrockets at one U.S. center
Federal Practitioner
Cancer prevalence among COVID-19 patients may be higher than previously reported
Federal Practitioner
ASCO announces its own COVID-19 and cancer registry
Federal Practitioner
Cancer care ‘transformed in space of a month’ because of pandemic
Federal Practitioner
Can convalescent plasma treat COVID-19 patients?
Federal Practitioner
Cancer patients report delays in treatment because of COVID-19
Federal Practitioner
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Federal Practitioner